Artificial intelligence technologies for COVID-19 de novo drug design

G Floresta, C Zagni, D Gentile, V Patamia… - International journal of …, 2022 - mdpi.com
The recent covid crisis has provided important lessons for academia and industry regarding
digital reorganization. Among the fascinating lessons from these times is the huge potential …

[HTML][HTML] In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

MM Rahman, MR Islam, S Akash, SA Mim… - Frontiers in Cellular …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
substantial number of deaths around the world, making it a serious and pressing public …

Emerging strategies on in silico drug development against COVID-19: challenges and opportunities

M Yadav, S Dhagat, JS Eswari - European Journal of Pharmaceutical …, 2020 - Elsevier
The importance of coronaviruses as human pathogen has been highlighted by the recent
outbreak of SARS-CoV-2 leading to the search of suitable drugs to overcome respiratory …

Application of artificial intelligence to address issues related to the COVID-19 Virus

M Senthilraja - SLAS TECHNOLOGY: Translating Life …, 2021 - journals.sagepub.com
Artificial intelligence (AI) plays a major role in addressing novel coronavirus 2019 (COVID-
19)-related issues and is also used in computer-aided synthesis planning (CASP). AI …

COVID-19 drug discovery using intensive approaches

A Asai, M Konno, M Ozaki, C Otsuka… - International journal of …, 2020 - mdpi.com
Since the infectious disease caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was reported in China during December 2019, the coronavirus disease 2019 …

[HTML][HTML] Modern drug discovery applications for the identification of novel candidates for COVID-19 infections

I Rani, A Kalsi, G Kaur, P Sharma, S Gupta… - Annals of Medicine and …, 2022 - Elsevier
In early December 2019, a large pneumonia epidemic occurred in Wuhan, China. The World
Health Organization is concerned about the outbreak of another coronavirus with the …

Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review

K Kaushal, P Sarma, SV Rana, B Medhi… - Journal of …, 2022 - Taylor & Francis
To elucidate the role of artificial intelligence (AI) in therapeutics for coronavirus disease
2019 (COVID-19). Five databases were searched (December 2019–May 2020). We …

An updated review of computer‐aided drug design and its application to COVID‐19

AB Gurung, MA Ali, J Lee, MA Farah… - BioMed research …, 2021 - Wiley Online Library
The recent outbreak of the deadly coronavirus disease 19 (COVID‐19) pandemic poses
serious health concerns around the world. The lack of approved drugs or vaccines continues …

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus

CA Omolo, N Soni, VO Fasiku, I Mackraj… - European Journal of …, 2020 - Elsevier
The global pandemic of coronavirus disease 2019 (COVID-19), caused by novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …

[HTML][HTML] AI-driven drug discovery: A boon against COVID-19?

AC Kaushik, U Raj - Ai Open, 2020 - Elsevier
The COVID-19 is an issue of international concern and threat to public health and there is an
urgent need of drug/vaccine design. There is no vaccine or specific drug yet made as of July …